TPO-RA Plus Baricitinib vs. TPO-RA for ITP

Clinical trial NCT07669675 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07669675
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ITP - Immune Thrombocytopenia

Start date: 2026-07-01
Primary completion: 2027-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.